Abstract
The aim of this work was to investigate the antibacterial activity of clove (Syzygium aromaticum) essential oil against multidrug resistant clinical strains of Klebsiella pneumoniae ESBL+. Materials: The antibacterial activity of the oil was tested against standard strain Klebsiella pneumoniae ATCC 700603 and 60 clinical strains of Klebsiella pneumoniae isolated from patients with infections of the respiratory tract, abdominal cavity, urinary tract, skin and from the hospital environment. Methods: The agar dilution method was used to assess the inhibition of microbial growth at various concentrations of the clove oil. Susceptibility testing to antibiotics was carried out using disc-diffusion. Results: The results of experiments showed that clove essential oil possessed very strong activity against all of the clinical strains of extendedspectrum β-lactamase (ESBL)-producing ESBL+ from Klebsiella pneumoniae. Conclusions: The results of this study suggest the potential use of clove essential oil against K. pneumoniae ESBL+ that is responsible for infections difficult to treat. Essential oils my be an excellent alternative for synthetic preparations and, used in combination with antibiotics, may prevent antibiotic-resistant strain development.
Keywords: Clove essential oil, ESBL+, K. pneumoniae, Minimal Inhibitory Concentration.
Anti-Infective Agents
Title:The Susceptibility of Klebsiella pneumoniae ESBL+ Strains to Clove (Syzygium aromaticum) Essential Oil
Volume: 11 Issue: 2
Author(s): Monika Sienkiewicz, Danuta Kalemba and Malgorzata Wasiela
Affiliation:
Keywords: Clove essential oil, ESBL+, K. pneumoniae, Minimal Inhibitory Concentration.
Abstract: The aim of this work was to investigate the antibacterial activity of clove (Syzygium aromaticum) essential oil against multidrug resistant clinical strains of Klebsiella pneumoniae ESBL+. Materials: The antibacterial activity of the oil was tested against standard strain Klebsiella pneumoniae ATCC 700603 and 60 clinical strains of Klebsiella pneumoniae isolated from patients with infections of the respiratory tract, abdominal cavity, urinary tract, skin and from the hospital environment. Methods: The agar dilution method was used to assess the inhibition of microbial growth at various concentrations of the clove oil. Susceptibility testing to antibiotics was carried out using disc-diffusion. Results: The results of experiments showed that clove essential oil possessed very strong activity against all of the clinical strains of extendedspectrum β-lactamase (ESBL)-producing ESBL+ from Klebsiella pneumoniae. Conclusions: The results of this study suggest the potential use of clove essential oil against K. pneumoniae ESBL+ that is responsible for infections difficult to treat. Essential oils my be an excellent alternative for synthetic preparations and, used in combination with antibiotics, may prevent antibiotic-resistant strain development.
Export Options
About this article
Cite this article as:
Sienkiewicz Monika, Kalemba Danuta and Wasiela Malgorzata, The Susceptibility of Klebsiella pneumoniae ESBL+ Strains to Clove (Syzygium aromaticum) Essential Oil, Anti-Infective Agents 2013; 11 (2) . https://dx.doi.org/10.2174/2211352511311020010
DOI https://dx.doi.org/10.2174/2211352511311020010 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Up-Regulation of Gr1+CD11b+ Population in Spleen of Dextran Sulfate Sodium Administered Mice Works to Repair Colitis
Inflammation & Allergy - Drug Targets (Discontinued) 1,4-Benzothiazines-A Biologically Attractive Scaffold
Mini-Reviews in Medicinal Chemistry Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers
Current Medicinal Chemistry Immunobiology of Herpes Simplex Virus and Cytomegalovirus Infections of the Fetus and Newborn
Current Immunology Reviews (Discontinued) Regulation of Angiogenesis by Macrophages, Dendritic Cells, and Circulating Myelomonocytic Cells
Current Pharmaceutical Design Gene Transfer for Inherited Metabolic Disorders of the Liver: Immunological Challenges
Current Pharmaceutical Design The Inhibitory Effect of Cyclosporine A and Prednisolone on Both Cytotoxic CD8+ T Cells and CD4+CD25+ Regulatory T Cells
Current Signal Transduction Therapy Ocular Inflammatory Diseases: Molecular Pathogenesis and Immunotherapy
Current Molecular Medicine Re and Tc Complexes with Pyrazolyl-Containing Chelators: from Coordination Chemistry to Target-Specific Delivery of Radioactivity
Current Radiopharmaceuticals Biosensors for Antioxidant Evaluation in Biological Systems
Combinatorial Chemistry & High Throughput Screening TRAIL Gene Therapy: From Preclinical Development to Clinical Application
Current Gene Therapy Impact of the Somatotrope Growth Hormone (GH)/Insulin-Like Growth Factor 1 (IGF-1) Axis Upon Thymus Function: Pharmacological Implications in Regeneration of Immune Functions
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research The Concept of Dysregulated Signal Transduction and Gene Expression in the Pathophysiology of Mood Disorders
Current Psychiatry Reviews Poly(ADP-ribose): Structure, Physicochemical Properties and Quantification In Vivo, with Special Reference to Poly(ADP-ribose) Binding Protein Modules
Current Protein & Peptide Science QSAR of Pyrazole Oxadiazole Derivatives as s1p1 Agonists Studied by CoMFA, CoMSIA and Docking
Letters in Drug Design & Discovery Development of 5-Fluorouracil Derivatives as Anticancer Agents
Current Medicinal Chemistry New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway
Current Pharmaceutical Design Nardilysin, A Basic Residues Specific Metallopeptidase That Mediates Cell Migration and Proliferation
Protein & Peptide Letters